Area of research
Hepatology · Epidemiology
Research interest
Research focused on Hepatic stellate cell and Hepatocellular carcinoma, with related work in Leptin, Genotype, AMPK. Notable publications include 'Association of a Genetic Variation in a miR-191 Binding Site in MDM4 with Risk of Esophageal Squamous Cell Carcinoma', 'Enhanced autophagy contributes to protective effects of IL-22 against acetaminophen-induced liver injury', and 'Algorithm of Golgi protein 73 and liver stiffness accurately diagnoses significant fibrosis in chronic HBV infection'.
Statistical Cure After Hepatectomy for Hepatitis B Virus-Associated Hepatocellular Carcinoma: A Risk-Stratification Model
Impact of compliance to postoperative regular follow-up on long-term prognosis after curative resection for hepatocellular carcinoma: A multicenter analysis
Heterogeneity in prognosis for early-stage hepatocellular carcinoma after hepatectomy: A multicenter analysis of 4,623 patients across five major staging systems
A real-world multi-center RNA-seq benchmarking study using the Quartet and MAQC reference materials
Long-term outcomes following hepatectomy in patients with lean non-alcoholic fatty liver disease-associated hepatocellular carcinoma versus overweight and obese counterparts: A multicenter analysis
Efficacy and safety of sirolimus early conversion protocol in liver transplant patients with hepatocellular carcinoma: A single-arm, multicenter, prospective study
Design and synthesis of 2-((1H-indol-3-yl)thio)-N-phenyl-acetamides as novel dual inhibitors of respiratory syncytial virus and influenza virus A
Enhanced autophagy contributes to protective effects of IL-22 against acetaminophen-induced liver injury
Leptin up-regulates microRNA-27a/b-3p level in hepatic stellate cells
Algorithm of Golgi protein 73 and liver stiffness accurately diagnoses significant fibrosis in chronic <scp>HBV</scp> infection
GATA binding protein 2 mediates leptin inhibition of PPARγ1 expression in hepatic stellate cells and contributes to hepatic stellate cell activation
Downregulating sCLU Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Gemcitabine by Activating the Intrinsic Apoptosis Pathway
Association of a Genetic Variation in a miR-191 Binding Site in MDM4 with Risk of Esophageal Squamous Cell Carcinoma